Browse the detailed record of transactions filed by 유한양행. Officer active across 1 company, notably 에이프릴바이오. Cumulatively, 12 reports have been published. Regulator: DART (FSS). The full history is accessible without signup.
Declarations 12 total
● Executives · 19 Nov 2024 (filed) · 에이프릴바이오 2,155,750 shares DART:20241119000001 ● Executives · 2 Aug 2024 (filed) · 에이프릴바이오 2,155,750 shares DART:20240802000310 Ideal exit: 29 Apr 2025 (T+270) ● Executives · 11 Sept 2023 (filed) · 에이프릴바이오 2,155,750 shares DART:20230911000314 Ideal exit: 7 Jun 2024 (T+270) ● Executives · 10 May 2023 (filed) · 에이프릴바이오 2,155,750 shares DART:20230510000830 Ideal exit: 4 Feb 2024 (T+270) ● Executives · 13 Sept 2022 (filed) · 에이프릴바이오 2,155,750 shares DART:20220913000287 Ideal exit: 10 Jun 2023 (T+270) ● Executives · 25 Aug 2022 (filed) · 에이프릴바이오 2,155,750 shares DART:20220825000523 Ideal exit: 22 May 2023 (T+270) ● Executives · 4 Aug 2022 (filed) · 에이프릴바이오 2,155,750 shares DART:20220804000092 Ideal exit: 1 May 2023 (T+270) ● Executives · 4 Aug 2022 (filed) · 에이프릴바이오 2,155,750 shares DART:20220804000211 Ideal exit: 1 May 2023 (T+270) ● Executives · 3 Aug 2022 (filed) · 에이프릴바이오 2,155,750 shares DART:20220803000305 Ideal exit: 30 Apr 2023 (T+270) ● Executives · 3 Aug 2022 (filed) · 에이프릴바이오 2,155,750 shares DART:20220803000226 Ideal exit: 30 Apr 2023 (T+270) ● Executives · 2 Aug 2022 (filed) · 에이프릴바이오 2,155,750 shares DART:20220802000068 Ideal exit: 29 Apr 2023 (T+270) ● Executives · 28 Jul 2022 (filed) · 에이프릴바이오 2,155,750 shares DART:20220728000316 Ideal exit: 24 Apr 2023 (T+270)